Walter A. Volberg - Concepedia

Author

Walter A. Volberg

Also Known As

W .A. VOLBERG, W A Volberg, W Volberg, W. A. VOLBERG, W. A. Volberg, Walter A Volberg, Walter A. Volberg, Walter Volberg

Publications

822

Citations

H-Index

Concepts

All Affiliations

Sterling Research Group (United States)South College Pfizer (United States)Winthrop University Rensselaer Polytechnic Institute

About

Walter A. Volberg is an author at Sterling Research Group (United States) specializing in medicine, electrophysiology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	359
2	Natural Sciences	3	3	110
3	Social Sciences	3	3	66
4	Health Sciences	2	2	88
5	Engineering	1	1	34

Walter A. Volberg

Publications

818

Citations

H-Index

Page 1

	Year	Citations
Blockade of Human Cardiac Potassium Channel Human Ether-a-go-go-Related Gene (HERG) by Macrolide Antibiotics Walter A. Volberg, Bryan Koci, Wei-guo Su, Journal of Pharmacology and Experimental Therapeutics	2002	150
Novel Potent Human Ether-à-Go-Go-Related Gene (hERG) Potassium Channel Enhancers and Their in Vitro Antiarrhythmic Activity Jun Zhou, Corinne E. Augelli‐Szafran, Jenifer A. Bradley, Molecular Pharmacology	2005	132
Chemical synthesis and characterization of ShK toxin: a potent potassium channel inhibitor from a sea anemone Michael W. Pennington, M. Byrnes, I. Zaydenberg, International journal of peptide & protein research	1995	103
Identification of a specific radioligand for the cardiac rapidly activating delayed rectifier K+ channel. C C Chadwick, Alan M. Ezrin, Brendan O’Connor, Circulation Research Class IiiCardiac MuscleCardiovascular PharmacologyPharmacotherapyExperimental Pharmacology	1993	54
Synthesis and Structure-Activity Relationships of 6-Heterocyclic-Substituted Purines as Inactivation Modifiers of Cardiac Sodium Channels Kimberly G. Estep, Kurt A. Josef, Edward R. Bacon, Journal of Medicinal Chemistry Cardiac MuscleHeart FailureInactivation ModifiersCardiovascular PharmacologyOrganic Chemistry	1995	47
Voltage Dependence of Cardiac Delayed Rectifier Block by Methanesulfonamide Class III Antiarrhythmic Agents Douglas S. Krafte, Walter A. Volberg Journal of Cardiovascular Pharmacology Heart FailureVoltage-dependent Channel BlockAnesthetic MechanismVoltage-clamp ExperimentsPharmacotherapy	1994	34
An impedance-based approach using human iPSC-derived cardiomyocytes significantly improves in vitro prediction of in vivo cardiotox liabilities Bryan Koci, Gregory C. Luerman, Anika Duenbostell, Toxicology and Applied Pharmacology MechanobiologyCardiac MuscleCardiomyopathyHeart FailureEngineering	2017	34
Novel Inhibitors of Potassium Ion Channels on Human T Lymphocytes William F. Michne, Joseph W. Guiles, Adi M. Treasurywala, Journal of Medicinal Chemistry	1995	33
(3<i>R</i>,4<i>S</i>)-3-[4-(4-Fluorophenyl)-4-hydroxypiperidin-1-yl]chroman-4,7-diol: A Conformationally Restricted Analogue of the NR2B Subtype-Selective NMDA Antagonist (1<i>S</i>,2<i>S</i>)-1-(4-Hydroxyphenyl)-2- (4-hydroxy-4-phenylpiperidino)-1-propanol Todd W. Butler, James F. Blake, Jon Bordner, Journal of Medicinal Chemistry Molecular PharmacologyPhenol RingBiochemistryG Protein-coupled ReceptorMedicine	1998	33
WIN 17317-3: novel nonpeptide antagonist of voltage-activated K+ channels in human T lymphocytes. Roger J. Hill, Alison M. Grant, Walter A. Volberg, Molecular Pharmacology	1995	31

Page 1